Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 6/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | UBE2N | P61088 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | MITF | O75030 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3417208 | 0.84 | MAPK1 (0.47) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL29630093 | 0.81 | MAPK1 (0.47) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL778350 | 0.81 | MAPK1 (0.47) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL10578179 | 0.81 | CNR2 (0.38) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL5053444 | 0.80 | MAPK1 (0.44) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL5551931 | 0.79 | MAPK1 (0.55) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL7452935 | 0.78 | SHBG (0.47) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL8765074 | 0.78 | MAPK1 (0.46) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL27984663 | 0.77 | MAPK1 (0.49) | MAPK1SMN1; SMN2NPSR1MEN1KMT2A | |
| SCHEMBL7452938 | 0.77 | CNR2 (0.49) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 791 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842744-B2 | excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound | ADEKA CORPORATION (JP) | 2010-11-30 | — | — | US | claimed |
| US-20090258976-A1 | excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound | NEGISHI YOSHINORI | 2009-10-15 | — | — | US | claimed |
| US-7553892-B2 | excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound | ADEKA CORPORATION (JP) | 2009-06-30 | — | — | US | claimed |
| US-6657083-B2 | Photographic couplers; acylation amine group in position 2 | EASTMAN KODAK COMPANY | 2003-12-02 | — | — | US | claimed |
| US-6613943-B2 | Intermediates for 4-substituted-2,5-diaminophenol derivatives as phenolic cyan couplers for color photography; deblocking the 2-acyl group by hydrolysis | EASTMAN KODAK COMPANY | 2003-09-02 | — | — | US | claimed |
| US-20030109716-A1 | 5-ACYLAMINO-2-AMINO-4-SUBSTITUTED-PHENOL COMPOUNDS AND METHOD OF USING THEM | EASTMAN KODAK COMPANY | 2003-06-12 | — | — | US | claimed |
| US-20030109753-A1 | 4-acylamino-2-hydroxy-5-substituted-acylanilide compounds and method of using them | EASTMAN KODAK COMPANY | 2003-06-12 | — | — | US | claimed |
| EP-1316550-A1 | 6-Acylamino-5-substituted-benzoxazol-2-one compounds and method for using them | EASTMAN KODAK COMPANY (US) | 2003-06-04 | — | — | EP | claimed |
| EP-1316544-A1 | 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them | EASTMAN KODAK COMPANY (US) | 2003-06-04 | — | — | EP | claimed |
| US-6525219-B1 | Chemical intermediates for cyan dye forming couplers; deblocking, hydrolysis, acylation | EASTMAN KODAK COMPANY | 2003-02-25 | — | — | US | claimed |
| US-6482953-B1 | 2-benzyloxy-4-nitro-5-substituted-acylanilide compounds and method of using them | EASTMAN KODAK COMPANY | 2002-11-19 | — | — | US | claimed |
| US-6476202-B1 | 5-acylamino-2-arylazo, nitro, or nitroso-4-substituted-phenol compounds and method of using them | EASTMAN KODAK COMPANY | 2002-11-05 | — | — | US | claimed |
| EP-0823068-B1 | COLOR-PROVIDING COMPOUNDS | POLAROID CORP (US) | 2000-08-09 | — | — | EP | claimed |
| US-5948607-A | DYE FORMING COUPLER; EXCELLENT IN COLOR REPRODUCIBILITY, SHARPNESS AND COLOR IMAGE FASTNESS. | FUJI PHOTO FILM CO., LTD. (JP) | 1999-09-07 | — | — | US | claimed |
| EP-0823068-A1 | COLOR-PROVIDING COMPOUNDS | POLAROID CORPORATION (US) | 1998-02-11 | — | — | EP | claimed |
| US-5717079-A | CONTAINING AT LEAST TWO 1,3-SULFUR-NITROGEN MOIETIES AND A COMPLETE DYE OR DYE INTERMEDIATE | POLAROID CORPORATION (US) | 1998-02-10 | — | — | US | claimed |
| WO-1997031295-A1 | COLOR-PROVIDING COMPOUNDS | POLAROID CORPORATION (US) | 1997-08-28 | — | — | WO | claimed |
| US-5585227-A | CONTAINING SPECIFIED YELLOW DYE-FORMING COUPLER AND CYAN COUPLER; REDUCED STAINING DURING PROCESSING AND STORAGE | FUJI PHOTO FILM CO., LTD. (JP) | 1996-12-17 | — | — | US | claimed |
| US-5557003-A | SOLVENT EXTRACTION OF ZINC FROM ORE | ZENECA LIMITED (GB) | 1996-09-17 | — | — | US | claimed |
| US-5409808-A | Excellent sensitivity and gradation; improved storage stability | FUJI PHOTO FILM CO., LTD. (JP) | 1995-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109753-A1 | 4-acylamino-2-hydroxy-5-substituted-acylanilide compounds and method of using them | CBR3, AADAC, HAAO | MAPK1 4592/4885SMN1; SMN2 4411/4885NPSR1 405/4885 |
| US-20030109716-A1 | 5-ACYLAMINO-2-AMINO-4-SUBSTITUTED-PHENOL COMPOUNDS AND METHOD OF USING THEM | AADAT, AAAS, ANXA7 | MAPK1 4456/4885SMN1; SMN2 3824/4885NPSR1 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.